Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.905 USD | +0.79% | +21.02% | -4.52% |
May. 14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
May. 13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.52% | 32.8M | |
+19.31% | 84.52B | |
-27.55% | 72.21B | |
+4.65% | 27.74B | |
-8.23% | 17.97B | |
-0.46% | 17.46B | |
+3.94% | 15.82B | |
+8.48% | 13.55B | |
+6.59% | 13.31B | |
+69.91% | 12.5B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $12.8M, vs. Street Est of $8.7M